These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16952273)

  • 1. Role of immunostimulatory DNA and TLR9 in gene therapy.
    Yasuda K; Wagner H; Takakura Y
    Crit Rev Ther Drug Carrier Syst; 2006; 23(2):89-110. PubMed ID: 16952273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9.
    Ohto U; Shibata T; Tanji H; Ishida H; Krayukhina E; Uchiyama S; Miyake K; Shimizu T
    Nature; 2015 Apr; 520(7549):702-5. PubMed ID: 25686612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro assay of immunostimulatory activities of plasmid vectors.
    Jiang W; Reich CF; Pisetsky DS
    Methods Mol Med; 2006; 127():55-70. PubMed ID: 16988446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Toll-like Receptor 9 Responses through Synthetic Immunostimulatory Motifs of DNA.
    Agrawal S; Kandimalla ER
    Ann N Y Acad Sci; 2003 Dec; 1002():30-42. PubMed ID: 14751820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunostimulatory DNA as a vaccine adjuvant.
    Higgins D; Marshall JD; Traquina P; Van Nest G; Livingston BD
    Expert Rev Vaccines; 2007 Oct; 6(5):747-59. PubMed ID: 17931155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in drug development of immunostimulatory CpG oligodeoxynucleotide ligands for TLR9.
    Vollmer J
    Expert Opin Biol Ther; 2005 May; 5(5):673-82. PubMed ID: 15934842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice.
    Spies B; Hochrein H; Vabulas M; Huster K; Busch DH; Schmitz F; Heit A; Wagner H
    J Immunol; 2003 Dec; 171(11):5908-12. PubMed ID: 14634101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR9 as a key receptor for the recognition of DNA.
    Kumagai Y; Takeuchi O; Akira S
    Adv Drug Deliv Rev; 2008 Apr; 60(7):795-804. PubMed ID: 18262306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways.
    Yasuda K; Yu P; Kirschning CJ; Schlatter B; Schmitz F; Heit A; Bauer S; Hochrein H; Wagner H
    J Immunol; 2005 May; 174(10):6129-36. PubMed ID: 15879108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA and its cationic lipid complexes induce CpG motif-dependent activation of murine dendritic cells.
    Yoshinaga T; Yasuda K; Ogawa Y; Nishikawa M; Takakura Y
    Immunology; 2007 Mar; 120(3):295-302. PubMed ID: 17199803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunophysiological impact of bacterial CpG DNA on the gut.
    Watson JL; McKay DM
    Clin Chim Acta; 2006 Feb; 364(1-2):1-11. PubMed ID: 16153626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA.
    Yasuda K; Rutz M; Schlatter B; Metzger J; Luppa PB; Schmitz F; Haas T; Heit A; Bauer S; Wagner H
    Eur J Immunol; 2006 Feb; 36(2):431-6. PubMed ID: 16421948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unmethylated CpG motifs in the L. donovani DNA regulate TLR9-dependent delay of programmed cell death in macrophages.
    Das S; Ghosh AK; Singh S; Saha B; Ganguly A; Das P
    J Leukoc Biol; 2015 Feb; 97(2):363-78. PubMed ID: 25473100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment and endo-lysosomal activation of TLR9 in dendritic cells infected with Trypanosoma cruzi.
    Bartholomeu DC; Ropert C; Melo MB; Parroche P; Junqueira CF; Teixeira SM; Sirois C; Kasperkovitz P; Knetter CF; Lien E; Latz E; Golenbock DT; Gazzinelli RT
    J Immunol; 2008 Jul; 181(2):1333-44. PubMed ID: 18606688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR9 and the recognition of self and non-self nucleic acids.
    Lamphier MS; Sirois CM; Verma A; Golenbock DT; Latz E
    Ann N Y Acad Sci; 2006 Oct; 1082():31-43. PubMed ID: 17145922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA motifs suppressing TLR9 responses.
    Trieu A; Roberts TL; Dunn JA; Sweet MJ; Stacey KJ
    Crit Rev Immunol; 2006; 26(6):527-44. PubMed ID: 17341193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
    Andersen JM; Al-Khairy D; Ingalls RR
    Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells.
    Heit A; Maurer T; Hochrein H; Bauer S; Huster KM; Busch DH; Wagner H
    J Immunol; 2003 Mar; 170(6):2802-5. PubMed ID: 12626528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice.
    Pavlenko M; Leder C; Moreno S; Levitsky V; Pisa P
    Vaccine; 2007 Aug; 25(34):6341-7. PubMed ID: 17628235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA.
    McCluskie MJ; Krieg AM
    Curr Top Microbiol Immunol; 2006; 311():155-78. PubMed ID: 17048708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.